BioSculpture Technology’s patented technology now makes it possible to safely and efficiently remove visceral or “belly” fat inside the abdomen for the first time. This method has the potential of becoming a safer and highly effective alternative to current bariatric surgical treatments of obesity, metabolic syndrome and type 2 diabetes mellitus.
- BioSculpture Technology, Inc. establishes Obesity Control Research & Development Division
- Recorded April 11 Traders Network Interview of BioSculpture Technology’s CEO Dr. Robert Cucin